Background: Rosacea is an inflammatory condition of the face characterized in its early stages by flushing, erythema and telangiectasias. Objectives: We evaluate the efficacy of long-pulsed Nd:YAG laser on erythematousteleangiectasic rosacea (ETR). Methods: In a retrospective case study of 21 patients (14F, 7M) with an average age of 29 years (range 19-41), were treated with two sessions at a distance of one month, with phototype up to III (5 phototype 1, 14 phototype II, 2 phototype III) with a fluence of 20 J/cm(2). Results: We observed a reduction of the erythematous component between 50% and 80% after two ses-sions, with an average pain score attributed to the treatment, measured by visual analogue scale (VAS), of 3. Conclusion: In this case series in which Nd:YAG laser had been used with a "'in motion" technique, we observed a reduction of the side effects and pain. (c) 2022 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Long-pulsed Nd:YAG laser using an "in motion" setting to treat telangiectatic rosacea
Dianzani, C;
2023-01-01
Abstract
Background: Rosacea is an inflammatory condition of the face characterized in its early stages by flushing, erythema and telangiectasias. Objectives: We evaluate the efficacy of long-pulsed Nd:YAG laser on erythematousteleangiectasic rosacea (ETR). Methods: In a retrospective case study of 21 patients (14F, 7M) with an average age of 29 years (range 19-41), were treated with two sessions at a distance of one month, with phototype up to III (5 phototype 1, 14 phototype II, 2 phototype III) with a fluence of 20 J/cm(2). Results: We observed a reduction of the erythematous component between 50% and 80% after two ses-sions, with an average pain score attributed to the treatment, measured by visual analogue scale (VAS), of 3. Conclusion: In this case series in which Nd:YAG laser had been used with a "'in motion" technique, we observed a reduction of the side effects and pain. (c) 2022 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.